TrialRecruiting
Targeting Osteosarcopaenia and Multimorbidity for Frailty Prevention (OPTIMA-C)
Targeting Osteosarcopaenia and Multimorbidity for Frailty Prevention Through Identification and Deep Phenotyping Methods in Healthy Aging and High-burden Disease Cohorts.
- Sponsor
- Tan Tock Seng Hospital (Academic or other)
- Enrolment
- 500 planned
- Conditions
- Stroke; Traumatic Brain Injury; Knee Osteoarthritis; Breast Cancer
- Ages
- adults, older adults
- Registry
- NCT06073106
From the registry
The aging population and its accompanying burden from non-communicable chronic diseases predicts an increasing impact imposed by frailty on healthcare systems. This is due to a lack of normative data for older adults and reliable risk stratification methods to develop effective approaches to the prevention of frailty. In this study, the investigators plan to form a common dataset for phenotype identification, risk stratification of frailty and its targeted treatment plans in the at-risk and mildly frail population.
Primary outcomes
- Incidence (rates) of Frailty
- Severity of Frailty